Chronic wasting disease (CWD) is an infectious disease caused by prions. CWD is found in North American elk and deer, but has not been observed in humans.
Using a mouse model that expresses an altered form of the normal human prion protein, researchers at University of California, San Diego School of Medicine have determined why the human proteins aren't corrupted when exposed to the elk prions. Their study, published Feb. 23 in the Journal of Clinical Investigation, identifies a small loop in the human prion protein that confers resistance to chronic wasting disease.
"Since the loop has been found to be a key segment in prion protein aggregation, this site could be targeted for the development of new therapeutics designed to block prion conversion," said Christina Sigurdson, DVM, PhD, associate professor at UC San Diego and UC Davis and senior author of the study.
"We suspected that a loop in the human prion protein structure may block the elk prions from binding, as the sequences did not appear to be compatible," Sigurdson said.
To test this hypothesis, Sigurdson and her team developed a transgenic mouse that expresses a prion protein that's identical to the human version - except for a small loop, which they swapped out for the elk prion sequence. When these mice were exposed to the elk prions, they developed chronic wasting disease.
In contrast, control mice expressing the normal human prion sequence resisted infection when exposed to same materials - just as humans seem to, even those who consume venison meat.
"This finding suggests that the loop structure is crucial to prion conversion and that sequence compatibility with the host prion protein at this site is required for the transmission of certain prion diseases," Sigurdson said.
Co-authors of this study include Timothy D. Kurt, Cyrus Bett, Jun Liu, Tom Yang, UC San Diego; Lin Jiang, David Eisenberg, UC Los Angeles and Howard Hughes Medical Institute; Natalia Fernandez-Borges, CIC bioGUNE, Spain; Terry R. Spraker, Colorado State University, Fort Collins; JoaquĆn Castilla, CIC bioGUNE and Basque Foundation for Science, Spain; and Qingzhong Kong, Case Western Reserve University.
This research was funded, in part, by the National Institutes of Health (grants NS055116, NS069566, U54AI0359 and AG029430), national grants from Spain and the Morris Animal Foundation.